Literature DB >> 3890590

The disulfiram-alcohol reaction: factors determining and potential tests predicting severity.

C Beyeler, H U Fisch, R Preisig.   

Abstract

13 ambulatory alcoholics (3 women, 10 men) who consented to alcohol-aversive treatment with disulfiram were subjected to detailed investigations before, during, and after the disulfiram-alcohol reaction (DAR). The studies included quantitative estimation of liver function (aminopyrine breath test, ABT; galactose elimination capacity, GEC) prior to the DAR, measurement of alcohol and acetaldehyde plasma levels together with pulse rate and blood pressure during the DAR, and the effects of disulfiram on erythrocyte acetaldehyde-oxidizing capacity (AOC). As expected, the severity of the DAR showed considerable interindividual variation. However, the maximal fall in diastolic blood pressure was closely (r = 0.83; p less than 0.001; n = 13) related to peak acetaldehyde plasma level (AAPL). The decrease in systolic blood pressure was age dependent, individuals greater than 40 years exhibiting a larger drop for a given AAPL. The dependence of acetaldehyde formation on liver function was suggested by a significant correlation (r = 0.88; p less than 0.01; n = 8) between ABT and AAPL; this relationship was influenced by the prior intake of enzyme-inducing drugs. Measurements of AOC indicated that a disulfiram-induced maximal suppression is achieved already after 6 days of treatment reaching levels of 0.7 +/- 0.6 nmol/ml/min (SD) (compared to pretreatment values of 4.1 +/- 0.9). Mean values in untreated alcoholics and in subjects with alcoholic or nonalcoholic liver disease were not significantly different from controls.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3890590     DOI: 10.1111/j.1530-0277.1985.tb05531.x

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  5 in total

1.  Hypersensitivities for acetaldehyde and other agents among cancer cells null for clinically relevant Fanconi anemia genes.

Authors:  Soma Ghosh; Surojit Sur; Sashidhar R Yerram; Carlo Rago; Anil K Bhunia; M Zulfiquer Hossain; Bogdan C Paun; Yunzhao R Ren; Christine A Iacobuzio-Donahue; Nilofer A Azad; Scott E Kern
Journal:  Am J Pathol       Date:  2013-11-06       Impact factor: 4.307

2.  The role of acetaldehyde in the pathogenesis of acute alcoholic pancreatitis.

Authors:  I H Nordback; S MacGowan; J J Potter; J L Cameron
Journal:  Ann Surg       Date:  1991-12       Impact factor: 12.969

3.  Effects on endogenous acetaldehyde production by disulfiram and ethanol feeding on rat pancreas.

Authors:  Z J He; P Ericksson; H Alho; A Harmoinen; I Nordback
Journal:  J Gastrointest Surg       Date:  2001 Sep-Oct       Impact factor: 3.452

Review 4.  Safety issues concerning the use of disulfiram in treating alcohol dependence.

Authors:  J Chick
Journal:  Drug Saf       Date:  1999-05       Impact factor: 5.606

5.  A double-blind, placebo-controlled assessment of the safety of potential interactions between intravenous cocaine, ethanol, and oral disulfiram.

Authors:  John D Roache; Roberta Kahn; Thomas F Newton; Christopher L Wallace; William L Murff; Richard De La Garza; Oscar Rivera; Ann Anderson; Jurij Mojsiak; Ahmed Elkashef
Journal:  Drug Alcohol Depend       Date:  2011-06-21       Impact factor: 4.492

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.